Renalytix (Reg S) (RENX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.04p
   
  • Change Today:
      0.043p
  • 52 Week High: 12.50p
  • 52 Week Low: 5.62p
  • Currency: UK Pounds
  • Shares Issued: 405.37m
  • Volume: 1,281,061
  • Market Cap: £36.66m
  • RiskGrade: 348

Latest Deals

Traded Action Notifier PriceAmountValue
26-Sep-25 Placing Robert (Rob) Graham Naylor 9.50p 105,263 £9,999.98
26-Sep-25 Placing Catherine Coste 9.50p 105,263 £9,999.98
26-Sep-25 Placing Christopher H B Mills 9.50p 2,500,000 £237,500.00
10-Dec-24 Buy James Renwick McCullough 8.50p 25,000 £2,125.00
05-Dec-24 Buy Christopher H B Mills 7.00p 48,601 £3,402.07
05-Dec-24 Buy James Renwick McCullough 7.50p 53,300 £3,997.50

Latest Notification of Holdings

No notifications of holding were found in the last 365 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 9.04p
Change Today 0.043p
% Change 0.48 %
52 Week High 12.50p
52 Week Low 5.62p
Volume 1,281,061
Shares Issued 405.37m
Market Cap £36.66m
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

RENX Dividends

No dividends found

Trades for 14-Oct-2025

Time Volume / Share Price
13:45 20,000 @ 8.75p
13:32 5,219 @ 8.98p
12:59 5,000 @ 8.91p
12:48 3,000 @ 8.74p
12:24 5,100 @ 8.74p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page